自己免疫疾患の治療市場2020：地域の見通し（アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ）別のサイズ、業界分析レポート、成長の可能性、価格動向、競争力のある市場シェア、市場統計と予測2020-2025 (アップデート版あり)

このレポートには、最新の市場図、統計、データが含まれています

ライセンスを選択

概要
目次

まとめグローバル自己免疫疾患の治療市場は、世界中で2015年から2019年にかけてCAGR xx％でxxx百万米ドルに達しました。将来的には、2020年から2025年までのCAGR xx％で2020年にxxx百万米ドルに達すると予測されています。
レポートは、主にヨーロッパとアジア太平洋、北アメリカ、中東とアフリカ、南アメリカのグローバル自己免疫疾患の治療市場に焦点を当てています。このレポートは、地域、メーカー、アプリケーション、および種類に基づいて市場を分割しました。

さらに、このレポートは、ベンダー間の市場競争状況と会社概要を紹介します。また、市場価格分析とバリューチェーン機能もこのレポートでカバーされています。

メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Abbott Laboratories
Active Biotech
Eli Lilly
AstraZeneca
Lupin
Amgen
Bristol-Myers Squibb
AutoImmune
Pfizer
GlaxoSmithKline
F. Hoffmann-La Roche
Johnson & Johnson

地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ （ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋地域 （中国、日本、韓国、インド、東南アジア）
南アメリカ （ブラジル、アルゼンチン、コロンビアなど）
中東とアフリカ （サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）

タイプによる市場セグメンテーションは以下をカバーします：
輸血
サプリメント
薬物
理学療法
他の
アプリケーションによる市場細分化：
病院
医療センター
他の
ドライバー、拘束、および機会とは別に、レポートはまた、業界で重要な位置を確立するためにプロファイルされたプレーヤーによって採用されたさまざまな成長戦略を含む、競争力のある風景を提供します。包括的なレポートに含まれるセグメンテーションは、立派なメーカーが地域に処理ユニットを設置し、グローバルな存在感を高めるのに役立ちます。これは業界にも利益をもたらし、会社の製品ポートフォリオを増やします。

この調査は、次の重要な質問に対する回答を提供します。
• 2020年から2025年の予測期間における自己免疫疾患の治療市場の推定成長率と市場シェアおよび規模はどのくらいですか？
• 予測期間2020年から2025年の自己免疫疾患の治療市場の原動力は何ですか？
• 著名なマーケットプレーヤーは誰ですか？彼らは他の競合他社に対してどのように競争力を獲得しましたか？
• 世界中の自己免疫疾患の治療の業界の進歩に影響を与える市場動向は何ですか？
• 業界の進歩を制限する主な課題と脅威は何ですか？
• 市場は著名な市場プレーヤーにとってどのような機会を持っていますか？
このレポートに関する特別な要件がある場合は、お知らせください。カスタムレポートを提供できます。

注–より正確な市場予測を提供するために、COVID-19の影響を考慮して、すべてのレポートが配信前に更新されます。

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Autoimmune Diseases Treatment Market Size Growth Rate by Type (2020-2025)
1.3.2 Blood Transfusion
1.3.3 Supplements
1.3.4 Drugs
1.3.5 Physical Therapy
1.3.6 Other
1.4 Market Segment by Application
1.4.1 Global Autoimmune Diseases Treatment Market Share by Application (2020-2025)
1.4.2 Hospital
1.4.3 Medical Center
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Autoimmune Diseases Treatment Production Value 2015-2025
2.1.2 Global Autoimmune Diseases Treatment Production 2015-2025
2.1.3 Global Autoimmune Diseases Treatment Capacity 2015-2025
2.1.4 Global Autoimmune Diseases Treatment Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Autoimmune Diseases Treatment Market Size CAGR of Key Regions
2.2.2 Global Autoimmune Diseases Treatment Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Autoimmune Diseases Treatment Capacity by Manufacturers
3.1.2 Global Autoimmune Diseases Treatment Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Autoimmune Diseases Treatment Revenue by Manufacturers (2015-2019)
3.2.2 Autoimmune Diseases Treatment Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Autoimmune Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.3 Autoimmune Diseases Treatment Price by Manufacturers
3.4 Key Manufacturers Autoimmune Diseases Treatment Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Autoimmune Diseases Treatment Market
3.6 Key Manufacturers Autoimmune Diseases Treatment Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Blood Transfusion Production and Production Value (2015-2019)
4.1.2 Supplements Production and Production Value (2015-2019)
4.1.3 Drugs Production and Production Value (2015-2019)
4.1.4 Physical Therapy Production and Production Value (2015-2019)
4.1.5 Other Production and Production Value (2015-2019)
4.2 Global Autoimmune Diseases Treatment Production Market Share by Type
4.3 Global Autoimmune Diseases Treatment Production Value Market Share by Type
4.4 Autoimmune Diseases Treatment Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Autoimmune Diseases Treatment Consumption by Application

6 Production by Regions
6.1 Global Autoimmune Diseases Treatment Production (History Data) by Regions 2015-2019
6.2 Global Autoimmune Diseases Treatment Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Autoimmune Diseases Treatment Production Growth Rate 2015-2019
6.3.2 United States Autoimmune Diseases Treatment Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Autoimmune Diseases Treatment Import & Export
6.4 European Union
6.4.1 European Union Autoimmune Diseases Treatment Production Growth Rate 2015-2019
6.4.2 European Union Autoimmune Diseases Treatment Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Autoimmune Diseases Treatment Import & Export
6.5 China
6.5.1 China Autoimmune Diseases Treatment Production Growth Rate 2015-2019
6.5.2 China Autoimmune Diseases Treatment Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Autoimmune Diseases Treatment Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia

7 Autoimmune Diseases Treatment Consumption by Regions
7.1 Global Autoimmune Diseases Treatment Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Autoimmune Diseases Treatment Consumption by Type
7.2.2 United States Autoimmune Diseases Treatment Consumption by Application
7.3 European Union
7.3.1 European Union Autoimmune Diseases Treatment Consumption by Type
7.3.2 European Union Autoimmune Diseases Treatment Consumption by Application
7.4 China
7.4.1 China Autoimmune Diseases Treatment Consumption by Type
7.4.2 China Autoimmune Diseases Treatment Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Autoimmune Diseases Treatment Consumption by Type
7.5.2 Rest of World Autoimmune Diseases Treatment Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia

8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Autoimmune Diseases Treatment
8.1.4 Autoimmune Diseases Treatment Product Introduction
8.1.5 Abbott Laboratories Recent Development
8.2 Active Biotech
8.2.1 Active Biotech Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Autoimmune Diseases Treatment
8.2.4 Autoimmune Diseases Treatment Product Introduction
8.2.5 Active Biotech Recent Development
8.3 Eli Lilly
8.3.1 Eli Lilly Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Autoimmune Diseases Treatment
8.3.4 Autoimmune Diseases Treatment Product Introduction
8.3.5 Eli Lilly Recent Development
8.4 AstraZeneca
8.4.1 AstraZeneca Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Autoimmune Diseases Treatment
8.4.4 Autoimmune Diseases Treatment Product Introduction
8.4.5 AstraZeneca Recent Development
8.5 Lupin
8.5.1 Lupin Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Autoimmune Diseases Treatment
8.5.4 Autoimmune Diseases Treatment Product Introduction
8.5.5 Lupin Recent Development
8.6 Amgen
8.6.1 Amgen Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Autoimmune Diseases Treatment
8.6.4 Autoimmune Diseases Treatment Product Introduction
8.6.5 Amgen Recent Development
8.7 Bristol-Myers Squibb
8.7.1 Bristol-Myers Squibb Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Autoimmune Diseases Treatment
8.7.4 Autoimmune Diseases Treatment Product Introduction
8.7.5 Bristol-Myers Squibb Recent Development
8.8 AutoImmune
8.8.1 AutoImmune Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Autoimmune Diseases Treatment
8.8.4 Autoimmune Diseases Treatment Product Introduction
8.8.5 AutoImmune Recent Development
8.9 Pfizer
8.9.1 Pfizer Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Autoimmune Diseases Treatment
8.9.4 Autoimmune Diseases Treatment Product Introduction
8.9.5 Pfizer Recent Development
8.10 GlaxoSmithKline
8.10.1 GlaxoSmithKline Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Autoimmune Diseases Treatment
8.10.4 Autoimmune Diseases Treatment Product Introduction
8.10.5 GlaxoSmithKline Recent Development
8.11 F. Hoffmann-La Roche
8.12 Johnson & Johnson

9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Autoimmune Diseases Treatment Capacity, Production Forecast 2020-2025
9.1.2 Global Autoimmune Diseases Treatment Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Autoimmune Diseases Treatment Production and Value Forecast by Regions 2020-2025
9.2.2 Global Autoimmune Diseases Treatment Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Autoimmune Diseases Treatment Production Forecast by Type
9.7.2 Global Autoimmune Diseases Treatment Production Value Forecast by Type
9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Autoimmune Diseases Treatment Sales Channels
10.2.2 Autoimmune Diseases Treatment Distributors
10.3 Autoimmune Diseases Treatment Customers

11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter\'s Five Forces Analysis

12 Key Findings

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer